Nuclear Medicine Diagnostics Market by SPECT (Technetium-99m, Iodine, Thallium-201 and others) and PET (Rubidium-82, Fluorine-18, and others), by Application (cardiology, lymphoma, thyroid, neurology, oncology) and by Region - Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)

Nuclear Medicine Diagnostics Market by SPECT (Technetium-99m, Iodine, Thallium-201 and others) and PET (Rubidium-82, Fluorine-18, and others), by Application (cardiology, lymphoma, thyroid, neurology, oncology) and by Region - Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)

ID: 123 | Pages: 181 | December 2016 | Region: Global


The global nuclear medicine diagnostic market is estimated at $9.83 billion in 2015 and is expected to reach $18.27 billion by 2020, at a compound annual growth rate (CAGR) of 13.2%. Nuclear medicine is a branch of medicine that uses radiation to deliver information about the functioning of a person's specific organs or to treat a disease. In most cases, the information will assist the physicians to make a quick, accurate diagnosis of the patient's illness.

Over 10,000 hospitals worldwide practice radioisotopes in medicine, and about 90% of these procedures are for diagnosis. The most common radioisotope accustomed in diagnosis is technetium-99, with some 40-45 million procedures per year (around 16.7 million in USA, 550,000 in Australia), aggregating to 80% of all nuclear medicine procedures worldwide.

SPECT imaging is the most conventional modality for nuclear medicine applications such as nuclear cardiology procedures. However, the trend is soon going to flip upside down owing to shortage of molybdenum-99 isotope which is in turn will lead to deficiency of Technetium-99, which is the by-product of molybdenum. Therefore, PET imaging products which include hybrid PET-CT scanners will account for a potentially hefty market size in the near future.

The emerging market tendency will be a fusion of nuclear imaging with different diagnostic imaging products such as SPECT/CT, PET/CT and MRI/PET. This provides full range of imaging scans through the same unit and at the same time. PET market is expected to witness more growth compared to SPECT imaging as it delivers higher resolution images and the lack of availability of technetium-99m is forcing industry to look for alternative diagnostic procedures

Increasing usage of SPECT and PET in medical diagnostics, rising awareness among people about radiopharmaceuticals, and ready availability of radiopharmaceuticals are the major factors fuelling the growth of the market. However, short half- life of radioisotopes, regulatory guidelines, high capital investment and reimbursement issues are the major restrains for the nuclear medicine market growth.

The Nuclear Medicine Market is segmented into two major segments SPECT (Technetium-99m (TC-99m), Iodine (I-123) Thallium-201 (TL-201) and others) and PET (Rubidium-82 (RB-82), Fluorine-18, and others). By application, the market is categorized into SPECT (lymphoma, cardiology, neurology, thyroid and others) and PET (cardiology, oncology, neurology and others).

Furthermore, on the basis of geography, the market is segmented into North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa. North America accounts for the largest share of the nuclear medicine market, followed by Asia-Pacific and Europe.

Some of the major players In the global nuclear medicine market are Cardinal Health, Inc., Bracco Imaging S.p.A, GE Healthcare, Eczacibasi-Monrol Nuclear Products, Nordion, Inc., Bayer Healthcare, Lantheus Medical Imaging, Inc., Advanced Accelerator Applications S.A., IBA Molecular Imaging, and Mallinckrodt plc.

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                           

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                              

                2.2 Analysis Design                         

                2.3 Research Phases                      

                                2.3.1 Secondary Research            

                                2.3.2 Primary Research 

                                2.3.3 Econometric Modelling     

                                2.3.4 Expert Validation  

                2.4 Study Timeline                          

3. Overview                                      

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 New Developments                

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                      

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market               

5. Market Segmentation                                              

                5.1 By Type                        

                                5.1.1 SPECT        

                                                5.1.1.1 Technetium-99m

                                                5.1.1.2 Thallium-201

                                                5.1.1.3 Gallium-67

                                                5.1.1.4 Iodine-23

                                                5.1.1.5 Others

                                5.1.2 PET             

                                                5.1.2.1 Fluorine-18

                                                5.1.2.2 Rubidium-82

                                                5.1.2.3 Others

                5.2 By Application                           

                                5.2.1 Cardiology               

                                5.2.2 Lymphoma             

                                5.2.3 Thyroid     

                                5.2.4 Neurology

                                5.2.5 Oncology 

                                5.2.6 Others      

6. Geographical Analysis                                              

                6.1 North America                          

                                6.1.1 Introduction           

                                6.1.2 United States         

                                6.1.3 Canada     

                6.2 Europe                         

                                6.2.1 Introduction           

                                6.2.2 U.K             

                                6.2.3 Spain         

                                6.2.4 Germany 

                                6.2.5 Italy           

                                6.2.6 France      

                6.3 Asia-Pacific                 

                                6.3.1 Introduction           

                                6.3.2 China         

                                6.3.3 India          

                                6.3.4 Japan        

                                6.3.5 South Korea           

                6.4 Latin America                            

                                6.4.1 Introduction           

                                6.4.2 Brazil         

                                6.4.3 Argentina

                                6.4.4 Mexico     

                6.5 Middle East & Africa               

                                6.5.1 UAE           

                                6.5.2 Saudi Arabia           

                                6.5.3 Israel         

                                6.5.4 South Africa            

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental      

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services

                                7.2.5 Competitive Rivalry within the Industry      

8.Market Leaders' Analysis                                          

                8.1 GE Healthcare                           

                                8.1.1 Overview

                                8.1.2 Product Analysis   

                                8.1.3 Strategic Evaluation and Operations            

                                8.1.4 Financial analysis  

                                8.1.5 Legal issues            

                                8.1.6 Recent Developments       

                                8.1.7 SWOT analysis       

                                8.1.8 Analyst View          

                8.2 Cardinal Health Inc.                 

                8.3 Bracco Imaging S.p.A                              

                8.4 Eczacibasi-Monrol Nuclear Products                

                8.5 Nordion, Inc.                              

                8.6 Bayer Healthcare                     

                8.7 Lantheus Medical Imaging, Inc.                          

                8.8 Advanced Accelerator Applications S.A.                         

                8.9 IBA Molecular Imaging                           

                8.10 Mallinckrodt plc.                    

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                        

                9.3 Agreements, collaborations and Joint Ventures                          

                9.4 New Product Launches                          

10.Expert Opinions                                         

                10.1 Market Outlook                     

                10.2 Investment Opportunities                 

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Global, regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market

TitlePriceAdd To Cart
  1. Global Nuclear Medicine Diagnostics Market By Region, From 2015-2020 (USD Billion)
  2. Global Nuclear Medicine Diagnostics Market By Type, From 2015-2020 (USD Billion)
  3. Global SPECT Diagnostic Radioisotopes Market By Region, From 2015-2020 (USD Billion)
  4. Global PET Diagnostic Radioisotopes Market By Region, From 2015-2020 (USD Billion)
  5. Global Nuclear Medicine Diagnostics Market By Application, From 2015-2020 (USD Billion)
  6. Global Cardiology Market By Region, From 2015-2020 (USD Billion)
  7. Global Lymphoma Market By Region, From 2015-2020 (USD Billion)
  8. Global Thyroid Market By Region, From 2015-2020 (USD Billion)
  9. Global Neurology Market By Region, From 2015-2020 (USD Billion)
  10. Global Oncology Market By Region, From 2015-2020 (USD Billion)
  11. Global Other Applications Market By Region, From 2015-2020 (USD Billion)
  12. Global SPECT Diagnostic Radioisotopes Market By Type, From 2015-2020 ( USD Billion )
  13. Global Technetium-99m Market By Region, From 2015-2020 ( USD Billion )
  14. Global Thallium-201 Market By Region, From 2015-2020 ( USD Billion )
  15. Global Gallium-67 Market By Region, From 2015-2020 ( USD Billion )
  16. Global Iodine-23 Market By Region, From 2015-2020 ( USD Billion )
  17. Global Other SPECT Diagnostic Radioisotopes Market By Region, From 2015-2020 ( USD Billion )
  18. Global PET Diagnostic Radioisotopes Market By Type, From 2015-2020 ( USD Billion )
  19. Global Fluorine-18 Market By Region, From 2015-2020 ( USD Billion )
  20. Global Rubidium-82 Market By Region, From 2015-2020 ( USD Billion )
  21. Global Other PET Diagnostic Radioisotopes Market By Region, From 2015-2020 ( USD Billion )
  22. North America Nuclear Medicine Diagnostics Market By Region, From 2015-2020 (USD Billion)
  23. North America Nuclear Medicine Diagnostics Market By Type, From 2015-2020 (USD Billion)
  24. North America SPECT Diagnostic Radioisotopes Market By Region, From 2015-2020 (USD Billion)
  25. North America PET Diagnostic Radioisotopes Market By Region, From 2015-2020 (USD Billion)
  26. North America Nuclear Medicine Diagnostics Market By Application, From 2015-2020 (USD Billion)
  27. North America Cardiology Market By Region, From 2015-2020 (USD Billion)
  28. North America Lymphoma Market By Region, From 2015-2020 (USD Billion)
  29. North America Thyroid Market By Region, From 2015-2020 (USD Billion)
  30. North America Neurology Market By Region, From 2015-2020 (USD Billion)
  31. North America Oncology Market By Region, From 2015-2020 (USD Billion)
  32. North America Other Applications Market By Region, From 2015-2020 (USD Billion)
  33. North America SPECT Diagnostic Radioisotopes Market By Type, From 2015-2020 ( USD Billion )
  34. North America Technetium-99m Market By Region, From 2015-2020 ( USD Billion )
  35. North America Thallium-201 Market By Region, From 2015-2020 ( USD Billion )
  36. North America Gallium-67 Market By Region, From 2015-2020 ( USD Billion )
  37. North America Iodine-23 Market By Region, From 2015-2020 ( USD Billion )
  38. North America Other SPECT Diagnostic Radioisotopes Market By Region, From 2015-2020 ( USD Billion )
  39. North America PET Diagnostic Radioisotopes Market By Type, From 2015-2020 ( USD Billion )
  40. North America Fluorine-18 Market By Region, From 2015-2020 ( USD Billion )
  41. North America Rubidium-82 Market By Region, From 2015-2020 ( USD Billion )
  42. North America Other PET Diagnostic Radioisotopes Market By Region, From 2015-2020 ( USD Billion )
  43. United States Nuclear Medicine Diagnostics Market By Type, From 2015-2020 (USD Billion)
  44. United States Nuclear Medicine Diagnostics Market By Application, From 2015-2020 (USD Billion)
  45. Canada Nuclear Medicine Diagnostics Market By Type, From 2015-2020 (USD Billion)
  46. Canada Nuclear Medicine Diagnostics Market By Application, From 2015-2020 (USD Billion)
  47. United States SPECT Diagnostic Radioisotopes Market By Type, From 2015-2020 ( USD Billion )
  48. Canada SPECT Diagnostic Radioisotopes Market By Type, From 2015-2020 ( USD Billion )
  49. United States PET Diagnostic Radioisotopes Market By Type, From 2015-2020 ( USD Billion )
  50. Canada PET Diagnostic Radioisotopes Market By Type, From 2015-2020 ( USD Billion )
  51. Europe Nuclear Medicine Diagnostics Market By Region, From 2015-2020 (USD Billion)
  52. Europe Nuclear Medicine Diagnostics Market By Type, From 2015-2020 (USD Billion)
  53. Europe SPECT Diagnostic Radioisotopes Market By Region, From 2015-2020 (USD Billion)
  54. Europe PET Diagnostic Radioisotopes Market By Region, From 2015-2020 (USD Billion)
  55. Europe Nuclear Medicine Diagnostics Market By Application, From 2015-2020 (USD Billion)
  56. Europe Cardiology Market By Region, From 2015-2020 (USD Billion)
  57. Europe Lymphoma Market By Region, From 2015-2020 (USD Billion)
  58. Europe Thyroid Market By Region, From 2015-2020 (USD Billion)
  59. Europe Neurology Market By Region, From 2015-2020 (USD Billion)
  60. Europe Oncology Market By Region, From 2015-2020 (USD Billion)
  61. Europe Other Applications Market By Region, From 2015-2020 (USD Billion)
  62. Europe SPECT Diagnostic Radioisotopes Market By Type, From 2015-2020 ( USD Billion )
  63. Europe Technetium-99m Market By Region, From 2015-2020 ( USD Billion )
  64. Europe Thallium-201 Market By Region, From 2015-2020 ( USD Billion )
  65. Europe Gallium-67 Market By Region, From 2015-2020 ( USD Billion )
  66. Europe Iodine-23 Market By Region, From 2015-2020 ( USD Billion )
  67. Europe Other SPECT Diagnostic Radioisotopes Market By Region, From 2015-2020 ( USD Billion )
  68. Europe PET Diagnostic Radioisotopes Market By Type, From 2015-2020 ( USD Billion )
  69. Europe Fluorine-18 Market By Region, From 2015-2020 ( USD Billion )
  70. Europe Rubidium-82 Market By Region, From 2015-2020 ( USD Billion )
  71. Europe Other PET Diagnostic Radioisotopes Market By Region, From 2015-2020 ( USD Billion )
  72. U.K Nuclear Medicine Diagnostics Market By Type, From 2015-2020 (USD Billion)
  73. U.K Nuclear Medicine Diagnostics Market By Application, From 2015-2020 (USD Billion)
  74. Spain Nuclear Medicine Diagnostics Market By Type, From 2015-2020 (USD Billion)
  75. Spain Nuclear Medicine Diagnostics Market By Application, From 2015-2020 (USD Billion)
  76. Germany Nuclear Medicine Diagnostics Market By Type, From 2015-2020 (USD Billion)
  77. Germany Nuclear Medicine Diagnostics Market By Application, From 2015-2020 (USD Billion)
  78. Italy  Nuclear Medicine Diagnostics Market By Type, From 2015-2020 (USD Billion)
  79. Italy  Nuclear Medicine Diagnostics Market By Application, From 2015-2020 (USD Billion)
  80. France Nuclear Medicine Diagnostics Market By Type, From 2015-2020 (USD Billion)
  81. France Nuclear Medicine Diagnostics Market By Application, From 2015-2020 (USD Billion)
  82. U.K SPECT Diagnostic Radioisotopes Market By Type, From 2015-2020 ( USD Billion )
  83. Spain SPECT Diagnostic Radioisotopes Market By Type, From 2015-2020 ( USD Billion )
  84. Germany SPECT Diagnostic Radioisotopes Market By Type, From 2015-2020 ( USD Billion )
  85. Italy  SPECT Diagnostic Radioisotopes Market By Type, From 2015-2020 ( USD Billion )
  86. France SPECT Diagnostic Radioisotopes Market By Type, From 2015-2020 ( USD Billion )
  87. U.K PET Diagnostic Radioisotopes Market By Type, From 2015-2020 ( USD Billion )
  88. Spain PET Diagnostic Radioisotopes Market By Type, From 2015-2020 ( USD Billion )
  89. Germany PET Diagnostic Radioisotopes Market By Type, From 2015-2020 ( USD Billion )
  90. Italy  PET Diagnostic Radioisotopes Market By Type, From 2015-2020 ( USD Billion )
  91. France PET Diagnostic Radioisotopes Market By Type, From 2015-2020 ( USD Billion )
  92. Asia-Pacific Nuclear Medicine Diagnostics Market By Region, From 2015-2020 (USD Billion)
  93. Asia-Pacific Nuclear Medicine Diagnostics Market By Type, From 2015-2020 (USD Billion)
  94. Asia-Pacific SPECT Diagnostic Radioisotopes Market By Region, From 2015-2020 (USD Billion)
  95. Asia-Pacific PET Diagnostic Radioisotopes Market By Region, From 2015-2020 (USD Billion)
  96. Asia-Pacific Nuclear Medicine Diagnostics Market By Application, From 2015-2020 (USD Billion)
  97. Asia-Pacific Cardiology Market By Region, From 2015-2020 (USD Billion)
  98. Asia-Pacific Lymphoma Market By Region, From 2015-2020 (USD Billion)
  99. Asia-Pacific Thyroid Market By Region, From 2015-2020 (USD Billion)
  100. Asia-Pacific Neurology Market By Region, From 2015-2020 (USD Billion)
  101. Asia-Pacific Oncology Market By Region, From 2015-2020 (USD Billion)
  102. Asia-Pacific Other Applications Market By Region, From 2015-2020 (USD Billion)
  103. Asia-Pacific SPECT Diagnostic Radioisotopes Market By Type, From 2015-2020 ( USD Billion )
  104. Asia-Pacific Technetium-99m Market By Region, From 2015-2020 ( USD Billion )
  105. Asia-Pacific Thallium-201 Market By Region, From 2015-2020 ( USD Billion )
  106. Asia-Pacific Gallium-67 Market By Region, From 2015-2020 ( USD Billion )
  107. Asia-Pacific Iodine-23 Market By Region, From 2015-2020 ( USD Billion )
  108. Asia-Pacific Other SPECT Diagnostic Radioisotopes Market By Region, From 2015-2020 ( USD Billion )
  109. Asia-Pacific PET Diagnostic Radioisotopes Market By Type, From 2015-2020 ( USD Billion )
  110. Asia-Pacific Fluorine-18 Market By Region, From 2015-2020 ( USD Billion )
  111. Asia-Pacific Rubidium-82 Market By Region, From 2015-2020 ( USD Billion )
  112. Asia-Pacific Other PET Diagnostic Radioisotopes Market By Region, From 2015-2020 ( USD Billion )
  113. China Nuclear Medicine Diagnostics Market By Type, From 2015-2020 (USD Billion)
  114. China Nuclear Medicine Diagnostics Market By Application, From 2015-2020 (USD Billion)
  115. India Nuclear Medicine Diagnostics Market By Type, From 2015-2020 (USD Billion)
  116. India Nuclear Medicine Diagnostics Market By Application, From 2015-2020 (USD Billion)
  117. Japan Nuclear Medicine Diagnostics Market By Type, From 2015-2020 (USD Billion)
  118. Japan Nuclear Medicine Diagnostics Market By Application, From 2015-2020 (USD Billion)
  119. South Korea Nuclear Medicine Diagnostics Market By Type, From 2015-2020 (USD Billion)
  120. South Korea Nuclear Medicine Diagnostics Market By Application, From 2015-2020 (USD Billion)
  121. China SPECT Diagnostic Radioisotopes Market By Type, From 2015-2020 ( USD Billion )
  122. India SPECT Diagnostic Radioisotopes Market By Type, From 2015-2020 ( USD Billion )
  123. Japan SPECT Diagnostic Radioisotopes Market By Type, From 2015-2020 ( USD Billion )
  124. South Korea SPECT Diagnostic Radioisotopes Market By Type, From 2015-2020 ( USD Billion )
  125. China PET Diagnostic Radioisotopes Market By Type, From 2015-2020 ( USD Billion )
  126. India PET Diagnostic Radioisotopes Market By Type, From 2015-2020 ( USD Billion )
  127. Japan PET Diagnostic Radioisotopes Market By Type, From 2015-2020 ( USD Billion )
  128. South Korea PET Diagnostic Radioisotopes Market By Type, From 2015-2020 ( USD Billion )
  129. Latin America Nuclear Medicine Diagnostics Market By Region, From 2015-2020 (USD Billion)
  130. Latin America Nuclear Medicine Diagnostics Market By Type, From 2015-2020 (USD Billion)
  131. Latin America SPECT Diagnostic Radioisotopes Market By Region, From 2015-2020 (USD Billion)
  132. Latin America PET Diagnostic Radioisotopes Market By Region, From 2015-2020 (USD Billion)
  133. Latin America Nuclear Medicine Diagnostics Market By Application, From 2015-2020 (USD Billion)
  134. Latin America Cardiology Market By Region, From 2015-2020 (USD Billion)
  135. Latin America Lymphoma Market By Region, From 2015-2020 (USD Billion)
  136. Latin America Thyroid Market By Region, From 2015-2020 (USD Billion)
  137. Latin America Neurology Market By Region, From 2015-2020 (USD Billion)
  138. Latin America Oncology Market By Region, From 2015-2020 (USD Billion)
  139. Latin America Other Applications Market By Region, From 2015-2020 (USD Billion)
  140. Latin America SPECT Diagnostic Radioisotopes Market By Type, From 2015-2020 ( USD Billion )
  141. Latin America Technetium-99m Market By Region, From 2015-2020 ( USD Billion )
  142. Latin America Thallium-201 Market By Region, From 2015-2020 ( USD Billion )
  143. Latin America Gallium-67 Market By Region, From 2015-2020 ( USD Billion )
  144. Latin America Iodine-23 Market By Region, From 2015-2020 ( USD Billion )
  145. Latin America Other SPECT Diagnostic Radioisotopes Market By Region, From 2015-2020 ( USD Billion )
  146. Latin America PET Diagnostic Radioisotopes Market By Type, From 2015-2020 ( USD Billion )
  147. Latin America Fluorine-18 Market By Region, From 2015-2020 ( USD Billion )
  148. Latin America Rubidium-82 Market By Region, From 2015-2020 ( USD Billion )
  149. Latin America Other PET Diagnostic Radioisotopes Market By Region, From 2015-2020 ( USD Billion )
  150. Brazil Nuclear Medicine Diagnostics Market By Type, From 2015-2020 (USD Billion)
  151. Brazil Nuclear Medicine Diagnostics Market By Application, From 2015-2020 (USD Billion)
  152. Mexico Nuclear Medicine Diagnostics Market By Type, From 2015-2020 (USD Billion)
  153. Mexico Nuclear Medicine Diagnostics Market By Application, From 2015-2020 (USD Billion)
  154. Argentina Nuclear Medicine Diagnostics Market By Type, From 2015-2020 (USD Billion)
  155. Argentina Nuclear Medicine Diagnostics Market By Application, From 2015-2020 (USD Billion)
  156. Brazil SPECT Diagnostic Radioisotopes Market By Type, From 2015-2020 ( USD Billion )
  157. Mexico SPECT Diagnostic Radioisotopes Market By Type, From 2015-2020 ( USD Billion )
  158. Argentina SPECT Diagnostic Radioisotopes Market By Type, From 2015-2020 ( USD Billion )
  159. Brazil PET Diagnostic Radioisotopes Market By Type, From 2015-2020 ( USD Billion )
  160. Mexico PET Diagnostic Radioisotopes Market By Type, From 2015-2020 ( USD Billion )
  161. Argentina PET Diagnostic Radioisotopes Market By Type, From 2015-2020 ( USD Billion )
  162. Middle East & Africa Nuclear Medicine Diagnostics Market By Region, From 2015-2020 (USD Billion)
  163. Middle East & Africa Nuclear Medicine Diagnostics Market By Type, From 2015-2020 (USD Billion)
  164. Middle East & Africa SPECT Diagnostic Radioisotopes Market By Region, From 2015-2020 (USD Billion)
  165. Middle East & Africa PET Diagnostic Radioisotopes Market By Region, From 2015-2020 (USD Billion)
  166. Middle East & Africa Nuclear Medicine Diagnostics Market By Application, From 2015-2020 (USD Billion)
  167. Middle East & Africa Cardiology Market By Region, From 2015-2020 (USD Billion)
  168. Middle East & Africa Lymphoma Market By Region, From 2015-2020 (USD Billion)
  169. Middle East & Africa Thyroid Market By Region, From 2015-2020 (USD Billion)
  170. Middle East & Africa Neurology Market By Region, From 2015-2020 (USD Billion)
  171. Middle East & Africa Oncology Market By Region, From 2015-2020 (USD Billion)
  172. Middle East & Africa Other Applications Market By Region, From 2015-2020 (USD Billion)
  173. Middle East & Africa SPECT Diagnostic Radioisotopes Market By Type, From 2015-2020 ( USD Billion )
  174. Middle East & Africa Technetium-99m Market By Region, From 2015-2020 ( USD Billion )
  175. Middle East & Africa Thallium-201 Market By Region, From 2015-2020 ( USD Billion )
  176. Middle East & Africa Gallium-67 Market By Region, From 2015-2020 ( USD Billion )
  177. Middle East & Africa Iodine-23 Market By Region, From 2015-2020 ( USD Billion )
  178. Middle East & Africa Other SPECT Diagnostic Radioisotopes Market By Region, From 2015-2020 ( USD Billion )
  179. Middle East & Africa PET Diagnostic Radioisotopes Market By Type, From 2015-2020 ( USD Billion )
  180. Middle East & Africa Fluorine-18 Market By Region, From 2015-2020 ( USD Billion )
  181. Middle East & Africa Rubidium-82 Market By Region, From 2015-2020 ( USD Billion )
  182. Middle East & Africa Other PET Diagnostic Radioisotopes Market By Region, From 2015-2020 ( USD Billion )
  183. UAE Nuclear Medicine Diagnostics Market By Type, From 2015-2020 (USD Billion)
  184. UAE Nuclear Medicine Diagnostics Market By Application, From 2015-2020 (USD Billion)
  185. Saudi Arabia Nuclear Medicine Diagnostics Market By Type, From 2015-2020 (USD Billion)
  186. Saudi Arabia Nuclear Medicine Diagnostics Market By Application, From 2015-2020 (USD Billion)
  187. Israel Nuclear Medicine Diagnostics Market By Type, From 2015-2020 (USD Billion)
  188. Israel Nuclear Medicine Diagnostics Market By Application, From 2015-2020 (USD Billion)
  189. South Africa Nuclear Medicine Diagnostics Market By Type, From 2015-2020 (USD Billion)
  190. South Africa Nuclear Medicine Diagnostics Market By Application, From 2015-2020 (USD Billion)
  191. UAE SPECT Diagnostic Radioisotopes Market By Type, From 2015-2020 ( USD Billion )
  192. Saudi Arabia SPECT Diagnostic Radioisotopes Market By Type, From 2015-2020 ( USD Billion )
  193. Israel SPECT Diagnostic Radioisotopes Market By Type, From 2015-2020 ( USD Billion )
  194. South Africa SPECT Diagnostic Radioisotopes Market By Type, From 2015-2020 ( USD Billion )
  195. UAE PET Diagnostic Radioisotopes Market By Type, From 2015-2020 ( USD Billion )
  196. Saudi Arabia PET Diagnostic Radioisotopes Market By Type, From 2015-2020 ( USD Billion )
  197. Israel PET Diagnostic Radioisotopes Market By Type, From 2015-2020 ( USD Billion )
  198. South Africa PET Diagnostic Radioisotopes Market By Type, From 2015-2020 ( USD Billion )

"We Think Through Different Layers, We Work Across Different Verticals."

Market Data Forecast, Inc.
502, kakatiya's empire,
Jubilee Gardens,
Hyderabad, India.
+1-888-702-9626 (U.S. TOLL FREE)
contact@marketdataforecast.com


Subscribe To Our News Letter

Or follow us on social platform

© 2017 Market Data Forecast
All Rights Reserved.